ICU Medical, Inc. (ICUI)
USD 143.42
(3.6%)
USD 143.42
(3.6%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.25 Billion USD | -7.04% |
| 2022 | 2.42 Billion USD | 816.38% |
| 2021 | 264.7 Million USD | 1.26% |
| 2020 | 261.42 Million USD | -17.04% |
| 2019 | 315.13 Million USD | -2.05% |
| 2018 | 321.73 Million USD | 7.71% |
| 2017 | 298.69 Million USD | 570.73% |
| 2016 | 44.53 Million USD | -5.16% |
| 2015 | 46.95 Million USD | 42.93% |
| 2014 | 32.85 Million USD | -5.92% |
| 2013 | 34.91 Million USD | -7.27% |
| 2012 | 37.65 Million USD | -7.1% |
| 2011 | 40.53 Million USD | 6.84% |
| 2010 | 37.94 Million USD | -14.06% |
| 2009 | 44.14 Million USD | 45.21% |
| 2008 | 30.4 Million USD | 5.97% |
| 2007 | 28.69 Million USD | 50.98% |
| 2006 | 19 Million USD | 31.82% |
| 2005 | 14.41 Million USD | 93.4% |
| 2004 | 7.45 Million USD | -10.03% |
| 2003 | 8.28 Million USD | -28.85% |
| 2002 | 11.64 Million USD | 9.19% |
| 2001 | 10.66 Million USD | 12.5% |
| 2000 | 9.48 Million USD | 28.11% |
| 1999 | 7.4 Million USD | 76.19% |
| 1998 | 4.2 Million USD | 27.27% |
| 1997 | 3.3 Million USD | 13.79% |
| 1996 | 2.9 Million USD | 31.82% |
| 1995 | 2.2 Million USD | 37.5% |
| 1994 | 1.6 Million USD | -23.81% |
| 1993 | 2.1 Million USD | 40.0% |
| 1992 | 1.5 Million USD | -37.5% |
| 1991 | 2.4 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.22 Billion USD | -1.53% |
| 2024 Q2 | 2.24 Billion USD | 1.27% |
| 2023 FY | 2.25 Billion USD | -7.04% |
| 2023 Q4 | 2.25 Billion USD | -1.03% |
| 2023 Q3 | 2.27 Billion USD | -2.97% |
| 2023 Q2 | 2.34 Billion USD | -0.93% |
| 2023 Q1 | 2.37 Billion USD | -2.29% |
| 2022 Q4 | 2.42 Billion USD | -0.49% |
| 2022 Q3 | 2.43 Billion USD | -2.65% |
| 2022 Q1 | 2.56 Billion USD | 870.07% |
| 2022 FY | 2.42 Billion USD | 816.38% |
| 2022 Q2 | 2.5 Billion USD | -2.48% |
| 2021 FY | 264.7 Million USD | 1.26% |
| 2021 Q2 | 245.57 Million USD | 0.46% |
| 2021 Q3 | 249.37 Million USD | 1.55% |
| 2021 Q4 | 264.7 Million USD | 6.15% |
| 2021 Q1 | 244.46 Million USD | -6.49% |
| 2020 Q3 | 277.31 Million USD | -38.0% |
| 2020 Q1 | 441.08 Million USD | 39.97% |
| 2020 Q2 | 447.26 Million USD | 1.4% |
| 2020 FY | 261.42 Million USD | -17.04% |
| 2020 Q4 | 261.42 Million USD | -5.73% |
| 2019 Q3 | 297.44 Million USD | -2.49% |
| 2019 Q4 | 315.13 Million USD | 5.95% |
| 2019 Q1 | 330.57 Million USD | 2.75% |
| 2019 Q2 | 305.05 Million USD | -7.72% |
| 2019 FY | 315.13 Million USD | -2.05% |
| 2018 FY | 321.73 Million USD | 7.71% |
| 2018 Q1 | 262.79 Million USD | -12.02% |
| 2018 Q3 | 284.86 Million USD | 5.79% |
| 2018 Q2 | 269.27 Million USD | 2.47% |
| 2018 Q4 | 321.73 Million USD | 12.94% |
| 2017 Q3 | 381.13 Million USD | 4.14% |
| 2017 Q2 | 365.97 Million USD | 10.49% |
| 2017 FY | 298.69 Million USD | 570.73% |
| 2017 Q4 | 298.69 Million USD | -21.63% |
| 2017 Q1 | 331.24 Million USD | 643.82% |
| 2016 Q4 | 44.53 Million USD | 10.72% |
| 2016 Q3 | 40.22 Million USD | -14.7% |
| 2016 FY | 44.53 Million USD | -5.16% |
| 2016 Q1 | 40.04 Million USD | -14.72% |
| 2016 Q2 | 47.15 Million USD | 17.75% |
| 2015 Q4 | 46.95 Million USD | 9.04% |
| 2015 Q1 | 36.24 Million USD | 10.33% |
| 2015 Q2 | 32.17 Million USD | -11.22% |
| 2015 FY | 46.95 Million USD | 42.93% |
| 2015 Q3 | 43.06 Million USD | 33.82% |
| 2014 FY | 32.85 Million USD | -5.92% |
| 2014 Q4 | 32.85 Million USD | -9.47% |
| 2014 Q3 | 36.28 Million USD | 6.57% |
| 2014 Q1 | 32.22 Million USD | -7.71% |
| 2014 Q2 | 34.05 Million USD | 5.66% |
| 2013 Q3 | 36.12 Million USD | -2.39% |
| 2013 Q2 | 37 Million USD | 7.59% |
| 2013 Q1 | 34.39 Million USD | -8.65% |
| 2013 Q4 | 34.91 Million USD | -3.33% |
| 2013 FY | 34.91 Million USD | -7.27% |
| 2012 FY | 37.65 Million USD | -7.1% |
| 2012 Q4 | 37.65 Million USD | -5.57% |
| 2012 Q3 | 39.87 Million USD | -2.9% |
| 2012 Q2 | 41.06 Million USD | 12.22% |
| 2012 Q1 | 36.59 Million USD | -9.72% |
| 2011 Q4 | 40.53 Million USD | 10.86% |
| 2011 FY | 40.53 Million USD | 6.84% |
| 2011 Q1 | 39.77 Million USD | 4.83% |
| 2011 Q2 | 39.22 Million USD | -1.38% |
| 2011 Q3 | 36.56 Million USD | -6.78% |
| 2010 Q4 | 37.94 Million USD | -0.54% |
| 2010 Q3 | 38.14 Million USD | -8.72% |
| 2010 Q2 | 41.78 Million USD | 0.74% |
| 2010 Q1 | 41.47 Million USD | -6.05% |
| 2010 FY | 37.94 Million USD | -14.06% |
| 2009 Q4 | 44.14 Million USD | 31.54% |
| 2009 Q3 | 33.56 Million USD | 9.57% |
| 2009 FY | 44.14 Million USD | 45.21% |
| 2009 Q2 | 30.63 Million USD | -6.95% |
| 2009 Q1 | 32.92 Million USD | 8.28% |
| 2008 Q3 | 29.75 Million USD | 3.01% |
| 2008 Q2 | 28.88 Million USD | 5.15% |
| 2008 Q4 | 30.4 Million USD | 2.18% |
| 2008 FY | 30.4 Million USD | 5.97% |
| 2008 Q1 | 27.47 Million USD | -4.25% |
| 2007 Q2 | 25.87 Million USD | 37.69% |
| 2007 Q4 | 28.69 Million USD | 10.44% |
| 2007 FY | 28.69 Million USD | 50.98% |
| 2007 Q1 | 18.79 Million USD | -1.1% |
| 2007 Q3 | 25.97 Million USD | 0.38% |
| 2006 FY | 19 Million USD | 31.82% |
| 2006 Q4 | 19 Million USD | 5.64% |
| 2006 Q1 | 14.74 Million USD | 2.29% |
| 2006 Q2 | 16.88 Million USD | 14.51% |
| 2006 Q3 | 17.98 Million USD | 6.54% |
| 2005 Q1 | 8.91 Million USD | 19.59% |
| 2005 Q3 | 14.15 Million USD | 1.33% |
| 2005 Q4 | 14.41 Million USD | 1.84% |
| 2005 FY | 14.41 Million USD | 93.4% |
| 2005 Q2 | 13.97 Million USD | 56.72% |
| 2004 FY | 7.45 Million USD | -10.03% |
| 2004 Q4 | 7.45 Million USD | -13.51% |
| 2004 Q3 | 8.61 Million USD | 1.44% |
| 2004 Q2 | 8.49 Million USD | 2.42% |
| 2004 Q1 | 8.29 Million USD | 0.12% |
| 2003 Q1 | 12.65 Million USD | 8.66% |
| 2003 Q4 | 8.28 Million USD | -10.84% |
| 2003 FY | 8.28 Million USD | -28.85% |
| 2003 Q3 | 9.29 Million USD | -7.17% |
| 2003 Q2 | 10.01 Million USD | -20.89% |
| 2002 FY | 11.64 Million USD | 9.19% |
| 2002 Q4 | 11.64 Million USD | 21.62% |
| 2002 Q3 | 9.57 Million USD | 2.07% |
| 2002 Q2 | 9.38 Million USD | -1.82% |
| 2002 Q1 | 9.55 Million USD | -10.41% |
| 2001 Q1 | 9.4 Million USD | -0.75% |
| 2001 Q4 | 10.66 Million USD | 1.7% |
| 2001 FY | 10.66 Million USD | 12.5% |
| 2001 Q3 | 10.48 Million USD | 17.7% |
| 2001 Q2 | 8.91 Million USD | -5.3% |
| 2000 FY | 9.48 Million USD | 28.11% |
| 2000 Q4 | 9.48 Million USD | 54.83% |
| 2000 Q3 | 6.12 Million USD | -9.62% |
| 2000 Q2 | 6.77 Million USD | -11.67% |
| 2000 Q1 | 7.67 Million USD | 3.65% |
| 1999 Q4 | 7.4 Million USD | 45.1% |
| 1999 Q1 | 5.2 Million USD | 23.81% |
| 1999 Q3 | 5.1 Million USD | -12.07% |
| 1999 FY | 7.4 Million USD | 76.19% |
| 1999 Q2 | 5.8 Million USD | 11.54% |
| 1998 Q3 | 4.2 Million USD | 2.44% |
| 1998 FY | 4.2 Million USD | 27.27% |
| 1998 Q1 | 3.9 Million USD | 18.18% |
| 1998 Q2 | 4.1 Million USD | 5.13% |
| 1998 Q4 | 4.2 Million USD | 0.0% |
| 1997 Q3 | 2 Million USD | 11.11% |
| 1997 Q1 | 2 Million USD | -31.03% |
| 1997 Q4 | 3.3 Million USD | 65.0% |
| 1997 Q2 | 1.8 Million USD | -10.0% |
| 1997 FY | 3.3 Million USD | 13.79% |
| 1996 Q1 | 2.3 Million USD | 4.55% |
| 1996 Q2 | 2.1 Million USD | -8.7% |
| 1996 Q3 | 2 Million USD | -4.76% |
| 1996 FY | 2.9 Million USD | 31.82% |
| 1996 Q4 | 2.9 Million USD | 45.0% |
| 1995 Q2 | 1.8 Million USD | 20.0% |
| 1995 Q1 | 1.5 Million USD | -6.25% |
| 1995 FY | 2.2 Million USD | 37.5% |
| 1995 Q4 | 2.2 Million USD | 15.79% |
| 1995 Q3 | 1.9 Million USD | 5.56% |
| 1994 Q2 | 1.8 Million USD | -14.29% |
| 1994 FY | 1.6 Million USD | -23.81% |
| 1994 Q1 | 2.1 Million USD | 0.0% |
| 1994 Q3 | 2.3 Million USD | 27.78% |
| 1994 Q4 | 1.6 Million USD | -30.43% |
| 1993 Q1 | 1.9 Million USD | 26.67% |
| 1993 Q2 | 1.7 Million USD | -10.53% |
| 1993 Q3 | 1.6 Million USD | -5.88% |
| 1993 Q4 | 2.1 Million USD | 31.25% |
| 1993 FY | 2.1 Million USD | 40.0% |
| 1992 FY | 1.5 Million USD | -37.5% |
| 1992 Q1 | 2.4 Million USD | 0.0% |
| 1992 Q4 | 1.5 Million USD | -11.76% |
| 1992 Q2 | 1.7 Million USD | -29.17% |
| 1992 Q3 | 1.7 Million USD | 0.0% |
| 1991 Q4 | 2.4 Million USD | 0.0% |
| 1991 FY | 2.4 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | -1681.238% |
| AngioDynamics, Inc. | 112.08 Million USD | -1911.892% |
| AtriCure, Inc. | 147.76 Million USD | -1426.102% |
| Avinger, Inc. | 19.97 Million USD | -11190.952% |
| Azenta, Inc. | 351.22 Million USD | -542.056% |
| BioLife Solutions, Inc. | 75.05 Million USD | -2904.662% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 45.105% |
| Daxor Corporation | 858.75 Thousand USD | -262491.906% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | -13724.356% |
| Femasys Inc. | 9.4 Million USD | -23881.414% |
| GlucoTrack, Inc. | 1.7 Million USD | -131927.459% |
| Harvard Bioscience, Inc. | 64.29 Million USD | -3407.48% |
| Hologic, Inc. | 4.02 Billion USD | 43.988% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | -10.314% |
| KORU Medical Systems, Inc. | 8.1 Million USD | -27715.136% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | -4513.587% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -341604.196% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -341604.196% |
| Masimo Corporation | 1.67 Billion USD | -34.492% |
| Microbot Medical Inc. | 3.82 Million USD | -58839.597% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | -8892.258% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | -100.76% |
| Nephros, Inc. | 3.5 Million USD | -64274.222% |
| NovoCure Limited | 783.63 Million USD | -187.766% |
| NEXGEL, Inc. | 4.78 Million USD | -46987.68% |
| NEXGEL, Inc. | 4.78 Million USD | -46987.68% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | -2508.146% |
| OraSure Technologies, Inc. | 52.17 Million USD | -4222.132% |
| Pro-Dex, Inc. | 23.34 Million USD | -9560.408% |
| Pulse Biosciences, Inc. | 16.44 Million USD | -13613.386% |
| Predictive Oncology Inc. | 6.14 Million USD | -36594.173% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | -32845.208% |
| QuidelOrtho Corporation | 3.55 Billion USD | 36.607% |
| Repligen Corporation | 853.2 Million USD | -164.3% |
| Sanara MedTech Inc. | 29.28 Million USD | -7600.778% |
| STAAR Surgical Company | 102.73 Million USD | -2094.932% |
| Sharps Technology, Inc. | 3.85 Million USD | -58396.486% |
| Utah Medical Products, Inc. | 7.14 Million USD | -31460.938% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 44.675% |
| Jin Medical International Ltd. | 8.92 Million USD | -25168.286% |